Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion type Assertion NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_head.
- NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion description "[PC-3 CM inhibited bone nodule formation and the activity of alkaline phosphatase (ALPase), an osteoblastic marker enzyme, on days 7, 14, and 21 (RC cells) or 3, 6, and 9 (ROS 17/2.8 cells) in a dose-dependent manner (5-30% CM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_provenance.
- NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion evidence source_evidence_literature NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_provenance.
- NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion SIO_000772 9328830 NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_provenance.
- NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion wasDerivedFrom befree-20140225 NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_provenance.
- NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_assertion wasGeneratedBy ECO_0000203 NP535296.RAAV-s39k0h8tA1fO8qpGmd3bq6C3rlDVDosTqh6xLz04130_provenance.